Private company
CONCERT PHARMACEUTICALS, INC.
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
-237.9%Operating margin3
-245.7%Net margin3
312.3%Revenue growth, 20213
-71.3%Return on equity3
-$55.4MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Research and development100¢$87.6M
Out of $32.6M in revenue.3 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $66.7M4 | $174.0K5 | $143.9M5 | $10.5M6 | $1.1M7 | $7.9M3 | $32.6M3 |
| Research and development | $28.9M4 | $37.0M5 | $30.2M5 | $43.1M6 | $59.8M7 | $61.6M3 | $87.6M3 |
| Operating income | $24.8M4 | -$51.2M5 | $92.6M5 | -$55.6M6 | -$79.0M7 | -$72.6M3 | -$77.5M3 |
| Income tax | $429.0K4 | $05 | -$300.0K5 | $313.0K6 | $07 | -$85.0K3 | $03 |
| Net income | $24.2M4 | -$50.7M5 | $95.6M5 | -$56.0M6 | -$78.2M7 | -$74.8M3 | -$80.1M3 |
| Earnings per share | $1.144 | -$2.285 | $4.205 | -$2.405 | -$2.403 | -$2.333 | |
| Earnings per share (diluted) | $1.094 | -$2.285 | $4.065 | -$2.405 | -$2.403 | -$2.333 |
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $92.5M4 | $40.6M4 | $27.7M5 | $17.8M6 | $53.0M7 | $77.2M3 | $141.6M3 |
| Current assets | $144.1M8 | $97.7M4 | $205.7M5 | $180.1M6 | $116.9M7 | $142.7M3 | $150.3M3 |
| Total assets | $146.9M8 | $100.4M4 | $211.7M5 | $192.5M6 | $137.5M7 | $159.3M3 | $165.3M3 |
| Current liabilities | $6.6M8 | $5.6M4 | $6.4M5 | $8.7M6 | $17.3M7 | $10.2M3 | $16.1M3 |
| Total liabilities | $16.3M8 | $14.8M4 | $15.3M5 | $24.8M6 | $36.0M7 | $28.1M3 | $53.1M3 |
| Shareholders’ equity | $130.6M5 | $85.6M5 | $196.4M6 | $167.7M7 | $101.5M3 | $131.2M3 | $112.2M3 |
| Shares outstanding | 22.2M shares8 | 22.3M shares4 | 23.1M shares5 | 23.4M shares6 | 23.9M shares7 | 31.9M shares3 | 32.1M shares3 |
Former names
- CONCERT PHARMACEUTICALS INCJun 16, 2006 to May 9, 20082
Recent filings
- Mar 6, 20238-K
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Mar 6, 20234 FORM 4 SUBMISSION
- Feb 16, 20234 FORM 4 SUBMISSION
- Feb 16, 20234 FORM 4 SUBMISSION
- Feb 16, 20234 FORM 4 SUBMISSION
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8